万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://www.journals.elsevier.com/journal-of-exotic-pet-medicine/
3、投稿网址：
https://www.editorialmanager.com/jepm/default.aspx
4、期刊刊期：季刊，逢季首月出版。
2021年6月24日星期四
投稿须知【官网信息】
Guide for Authors
Types of article
All the article types excluding narrative reviews will undergo peer-review. Based on the scope of the journal, articles should focus on medical conditions in exotic pets. Articles including wildlife or animals in zoological, production or laboratory setting that may have relevant clinical implications for pet exotic animals will be also considered.
All articles (except Correspondence) are expected to include a statement describing what sources (e.g., databases, proceedings) have been searched to determine novelty of the findings. The typical statement "To the authors' knowledge this is the first report?" is not considered acceptable.
Research articles report the results of original research, including case series in clinical setting. The material submitted should not have been previously published elsewhere. Research articles should shed additional light on one or more of the following aspects related to a condition in exotic pets:
Etiology
Frequency
Diagnosis
Treatment
Prognosis
Research articles are limited to 4000 words (excluding references), and should be divided in the following sections: Introduction, Materials and Methods, Results, Discussion. Case series including more than 6 animals should follow this format, while case series including 5 or less animals must provide individual case description (e.g., Case 1; Case 2; etc). The use of reporting guidelines, including CONSORT or ARRIVE for trials, STROBE for observational studies, STARD for diagnostic studies, PRISMA for systematic reviews, is highly encouraged.
Review articles are pre-approved narrative articles that cover subjects falling within the scope of the journal. Review articles are limited to 5000 words (excluding references). Systematic reviews do not fall in this category and should be submitted as "Research articles".
Case reports are reports meant to communicate symptoms, signs, diagnosis, treatment, and follow-up of an individual (n=1) exotic pet. Typically to be of interest for the journal substantial novelties on occurrence, diagnosis, treatment or prognosis for a condition are required. Simple descriptions of novel disease presentations (e.g., a neoplasm, a well-known infectious agent) where there is no additional information such as clinically-relevant diagnostics, treatments or long-term survival are not appropriate for this category of articles and should be submitted as "Correspondence". Case reports describing a treatment should not focus on the effectiveness of the intervention provided since research articles are required for such aim. Case reports are limited to 1500 words (excluding references), and should be divided in the following sections: Introduction (brief), Case presentation, Discussion.
Correspondence is intended to provide brief information on clinical cases or pilot research studies. Examples of material that will be considered as Correspondence include:
formerly described diseases or medical/surgical procedures being described in a new species
adverse events of diagnostic techniques or treatments
long term updates of previously published case reports or research studies
description of a disease in a previously unreported geographical area whenever this has epidemiologic implications
description of a technique employed in clinical setting
Correspondence is intended for works that are more concise than full Case Reports or Research Articles. Correspondence papers should be no longer than 500 words and have no subsections. No more than 1 figure (if a composite figure, no more than 3 panels) or 1 table should be used for Correspondence articles with a limit of 5 references.
Page charges
This journal has no page charges.
Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
All necessary files have been uploaded:
Manuscript:
• Include keywords
• All figures (include relevant captions)
• All tables (including titles, description, footnotes)
• Ensure all figure and table citations in the text match the files provided
• Indicate clearly if color should be used for any figures in print
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)
Further considerations
• Manuscript has been 'spell checked' and 'grammar checked'
• All references mentioned in the Reference List are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Internet)
• A competing interests statement is provided, even if the authors have no competing interests to declare
• Journal policies detailed in this guide have been reviewed
• Referee suggestions and contact details provided, based on journal requirements
Ethics in publishing
Please see our information on Ethics in publishing.
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
To be considered for publication in JEPM, all research studies involving animals must have been performed in compliance with guidelines outlined in the Animal Welfare Act, US Public Health Service Policy on the Humane Care and Use of Laboratory Animals, National Research Council’s Guide for the Care and Use of Laboratory Animals), or Guide for the Care and Use of Agricultural Animals in Research and Teaching or in compliance with equivalent guidelines. A manuscript containing information that suggests animals were subjected to adverse, stressful, or harsh conditions or treatments will not be considered for publication unless the authors demonstrate convincingly that the knowledge gained was of sufficient value to justify these conditions or treatments.
Where animals have been used in a study, the Institutional Animal Care and Use Committee (IACUC) or equivalent ethics review committee, under which the work was conducted, must be stated along with the specific authorisation reference number and the date of approval. This should be explicitly stated in the Materials and Methods section along with the name of the ethics review committee and any regional, national or international guidelines which have been followed. In all cases, unnecessary suffering or cruelty in animal experimentation will not be acceptable to the Editors of JEPM. The Editors may, at their discretion, reject any paper where there is reason to believe that animals have been subjected to unnecessary or avoidable pain or distress.
Declaration of competing interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of competing interest statement using this template and upload to the submission system at the Attach/Upload Files step. Note: Please do not convert the .docx template to another file type. Author signatures are not required. If there are no interests to declare, please choose the first option in the template. More information.
Submission declaration
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder.
Preprints
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Author contributions
For transparency, we encourage authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review & editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following. More details and an example
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Reporting clinical trials
Randomized controlled trials should be presented according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure. The CONSORT checklist and template flow diagram are available online.
To ensure thoroughness of reporting, authors of Scientific Reports are strongly encouraged to make use of the following guidelines when preparing manuscripts:
CONSORT (Consolidated Standards of Reporting Trials)—for clinical trials
STARD (Standards for the Reporting of Diagnostic Accuracy Studies)—for diagnostic test evaluation
REFLECT (Reporting Guidelines for Randomized Controlled Trials for Livestock and Food Safety)— for clinical trials in livestock and food safety
STROBE (Strengthening the Reporting of Observational Studies in Epidemiology)—for cross- sectional, case-control, and cohort studies
PRISMA (Preferred Reporting Items of Systematic Reviews and Meta-analyses)—for systematic reviews and meta-analyses
ARRIVE (Animal Research: Reporting of In Vivo Experiments)—for all studies involving laboratory animals
CARE (Case Report)—for clinical reports in general (note that JEPM requirements differ in formatting)
AGREE (Appraisal of Guidelines for Research and Evaluation)—for clinical practice guidelines
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases.
For gold open access articles: Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (more information). Permitted third party reuse of gold open access articles is determined by the author's choice of user license.
Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Open access
Please visit our Open Access page for more information.
Elsevier Researcher Academy
Researcher Academy is a free e-learning platform designed to support early and mid-career researchers throughout their research journey. The "Learn" environment at Researcher Academy offers several interactive modules, webinars, downloadable guides and resources to guide you through the process of writing for research and going through peer review. Feel free to use these free resources to improve your submission and navigate the publication process with ease.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's Author Services.
Submission
Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.
Submit your article
Please submit your article via https://www.editorialmanager.com/jepm
Peer review
This journal operates a double anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. Editors are not involved in decisions about papers which they have written themselves or have been written by family members or colleagues or which relate to products or services in which the editor has an interest. Any such submission is subject to all of the journal's usual procedures, with peer review handled independently of the relevant editor and their research groups. More information on types of peer review.
Use of word processing software
It is important that the file be saved in the native format of the word processor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the word processor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier). Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also the section on Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your word processor.
……
更多详情：
https://www.elsevier.com/journals/journal-of-exotic-pet-medicine/1557-5063/guide-for-authors
